MONICA CEPEDA: Open Payments
NPI 1053061804 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 76 payments from 15 companies in 2025. Trend: 2023 $839 · 2024 $822 · 2025 $1,416
Food & beverage: $1,378Education: $38
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 22 | $402 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $259 |
| Ardelyx, Inc. | 9 | $252 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $150 |
| Medtronic, Inc. | 1 | $64 |
| Amgen Inc. | 2 | $58 |
| Travere Therapeutics, Inc. | 5 | $42 |
| Vifor Pharma, Inc. | 2 | $40 |
| OPKO Pharmaceuticals, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: TARPEYO, Kerendia, IBSRELA, JARDIANCE, ELLIPSYS VASCULAR ACCESS SYSTEM, Veltassa, TAVNEOS, RAYALDEE.
Industry payments across TX — which companies pay providers there.
